85 related articles for article (PubMed ID: 19264544)
1. Human Papillomavirus negative but dyskaryotic cervical cytology: re-analysis of molecular testing.
Peevor R; Bowden S; Jones J; Fiander AN; Hibbitts S
J Clin Virol; 2009 Apr; 44(4):322-4. PubMed ID: 19264544
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the PapilloCheck DNA micro-array Human Papillomavirus detection assay with Hybrid Capture II and PCR-enzyme immunoassay using the GP5/6+ primer set.
Jones J; Powell NG; Tristram A; Fiander AN; Hibbitts S
J Clin Virol; 2009 Jun; 45(2):100-4. PubMed ID: 19394266
[TBL] [Abstract][Full Text] [Related]
3. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
[TBL] [Abstract][Full Text] [Related]
4. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the clinical performance of PapilloCheck human papillomavirus detection with that of the GP5+/6+-PCR-enzyme immunoassay in population-based cervical screening.
Hesselink AT; Heideman DA; Berkhof J; Topal F; Pol RP; Meijer CJ; Snijders PJ
J Clin Microbiol; 2010 Mar; 48(3):797-801. PubMed ID: 20042622
[TBL] [Abstract][Full Text] [Related]
6. A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings.
Jacobs MV; Snijders PJ; van den Brule AJ; Helmerhorst TJ; Meijer CJ; Walboomers JM
J Clin Microbiol; 1997 Mar; 35(3):791-5. PubMed ID: 9041439
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and risk factors for human papillomavirus DNA in cervical cytology.
Kasap B; Yetimalar H; Keklik A; Yildiz A; Cukurova K; Soylu F
Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):168-71. PubMed ID: 21764503
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of primers and PCR performance on HPV DNA screening in normal and low grade abnormal cervical cells.
Chaiwongkot A; Pientong C; Ekalaksananan T; Kongyingyoes B; Thinkhamrop J; Yuenyao P; Sriamporn S
Asian Pac J Cancer Prev; 2007; 8(2):279-82. PubMed ID: 17696746
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
[TBL] [Abstract][Full Text] [Related]
10. Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison.
Jacobs MV; Snijders PJ; Voorhorst FJ; Dillner J; Forslund O; Johansson B; von Knebel Doeberitz M; Meijer CJ; Meyer T; Nindl I; Pfister H; Stockfleth E; Strand A; Wadell G; Walboomers JM
J Clin Pathol; 1999 Jul; 52(7):498-503. PubMed ID: 10605401
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus prevalence in women attending routine cervical screening in South Wales, UK: a cross-sectional study.
Hibbitts S; Jones J; Powell N; Dallimore N; McRea J; Beer H; Tristram A; Fielder H; Fiander AN
Br J Cancer; 2008 Dec; 99(11):1929-33. PubMed ID: 19034285
[TBL] [Abstract][Full Text] [Related]
12. Validation of ThermoFisher's Papspin for human papillomavirus detection in cervicovaginal specimens using PCR with GP5+/GP6+ primers and the Hybrid Capture II assay.
Weynand B; Delvenne P; Polet R; Guiot Y; Arafa M; Somja J; Galant C
Clin Microbiol Infect; 2010 Jun; 16(6):671-5. PubMed ID: 19689463
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.
Walboomers JM; Jacobs MV; Manos MM; Bosch FX; Kummer JA; Shah KV; Snijders PJ; Peto J; Meijer CJ; Muñoz N
J Pathol; 1999 Sep; 189(1):12-9. PubMed ID: 10451482
[TBL] [Abstract][Full Text] [Related]
14. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.
Dartell MA; Rasch V; Iftner T; Kahesa C; Mwaiselage JD; Junge J; Gernow A; Ejlersen SF; Munk C; Kjaer SK
Int J Cancer; 2014 Aug; 135(4):896-904. PubMed ID: 24391021
[TBL] [Abstract][Full Text] [Related]
15. DNA image cytometry and human papillomavirus (HPV) detection help to select smears at high risk of high-grade cervical lesions.
Lorenzato M; Clavel C; Masure M; Nou JM; Bouttens D; Evrard G; Bory JP; Maugard B; Quereux C; Birembaut P
J Pathol; 2001 Jun; 194(2):171-6. PubMed ID: 11400145
[TBL] [Abstract][Full Text] [Related]
16. Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.
Učakar V; Poljak M; Oštrbenk A; Klavs I
J Med Virol; 2014 Oct; 86(10):1772-9. PubMed ID: 24978445
[TBL] [Abstract][Full Text] [Related]
17. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
[TBL] [Abstract][Full Text] [Related]
18. The development of a quality assurance programme for HPV testing within the UK NHS cervical screening LBC/HPV studies.
Cubie HA; Moore C; Waller M; Moss S;
J Clin Virol; 2005 Aug; 33(4):287-92. PubMed ID: 16036178
[TBL] [Abstract][Full Text] [Related]
19. HPV is detectable in virtually all abnormal cervical cytology samples after reinvestigation of HPV negatives with multiple alternative PCR tests.
Evans MF; Adamson CS; Schned LM; St John TL; Leiman G; Ashikaga T; Cooper K
Diagn Mol Pathol; 2010 Sep; 19(3):144-50. PubMed ID: 20736743
[TBL] [Abstract][Full Text] [Related]
20. Colposcopy is not necessary to assess the risk to the cervix in HIV-positive women: an international cohort study of cervical pathology in HIV-1 positive women.
Kitchener H; Nelson L; Adams J; Mesher D; Sasieni P; Cubie H; Moore C; Heard I; Agarossi A; Casolati E; Denny L; Bradbeer C; Lyons F; Beattie G; Niemiec T
Int J Cancer; 2007 Dec; 121(11):2484-91. PubMed ID: 17683070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
